...
首页> 外文期刊>Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders >A Double-Blind, Active-Controlled Clinical Trial of Sodium Bicarbonate and Calcium Gluconate in the Treatment of Bilateral Osteoarthritis of the Knee
【24h】

A Double-Blind, Active-Controlled Clinical Trial of Sodium Bicarbonate and Calcium Gluconate in the Treatment of Bilateral Osteoarthritis of the Knee

机译:碳酸氢钠和葡萄糖酸钙双盲,主动控制的临床试验治疗膝部双侧骨关节炎

获取原文

摘要

Objective:To evaluate the effect of intra-articular injections of sodium bicarbonate with a single (SBCG1) or double dose (SBCG2) of calcium gluconate administered monthly compared with methylprednisolone (MP) for treatment of knee osteoarthritis.Methods:A 3-month, randomized, double-blind clinical trial with patients diagnosed with knee osteoarthritis (OA). The outcome variables were the Western Ontario-McMaster University Osteoarthritis Index (WOMAC) and the Lequesne functional index.Results:After 3?months, all treatments significantly improved in overall WOMAC and Lequesne scores. Mean changes (95% confidence interval) in WOMAC total score and the Lequesne index, respectively, for SBCG1 (?12.5 [?14.3, ?10.7]; ?9.0 [?11.4, ?6.7]) and SBCG2 (?12.3 [?14.3, ?10.4]; ?8.9 [?10.4, ?7.4]) were significantly greater than for MP (?5.0 [?7.2, ?2.8]; ?3.2 [?4.9, ?1.5]) (P?
机译:目的:评价与甲基强的松龙(MP)相比每月一次单次(SBCG1)或双剂量(SBCG2)葡萄糖酸钙的碳酸氢钠关节腔注射治疗膝骨关节炎的方法。方法:3个月,一项诊断为膝骨关节炎(OA)的患者的随机,双盲临床试验。结果变量为Western Ontario-McMaster大学骨关节炎指数(WOMAC)和Lequesne功能指数。结果:3个月后,所有治疗的WOMAC和Lequesne总体得分均得到显着改善。 SBCG1(?12.5 [?14.3,?10.7] ;? 9.0 [?11.4,?6.7])和SBCG2(?12.3 [?14.3])的WOMAC总得分和Lequesne指数的平均变化(95%置信区间) ,?10.4] ;? 8.9 [?10.4,?7.4])显着大于MP(?5.0 [?7.2,?2.8];?3.2 [?4.9,?1.5])(P 。001)结论:关节内注射碳酸氢钠和葡萄糖酸钙可用于短期缓解双侧膝关节骨关节炎患者的OA症状。两种疗法在减轻膝OA症状方面均比MP注射更为有效。试验注册:Clinicaltrials.gov NCT00977444

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号